Effect of Flumazenil Drip On Speed Of Recovery And Prevention Of Complications In Severe Acute Benzodiazepine Toxicity
Phase 2
- Conditions
- Poisoning by, adverse effect of and underdosing of hydantoin derivativesT42.0Benzodiazepine poisoning.
- Registration Number
- IRCT20120629010133N3
- Lead Sponsor
- IMAD (National Institute for Medical Research Development)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Severely benzodiazepine-poisoned patients (in need for intubation and mechanical ventilation) with otherwise normal vital signs
Exclusion Criteria
Abnormal vital signs on presentation,
history of seizure,
history of ingestion or use of any drug/medication that can predispose the patient to seizure,
history of head trauma,
possible brain edema and increased intracranial pressure,
history of hypoxemia
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Mortality-. Timepoint: 7 days after admission. Method of measurement: Observation and questionnaire recording.;Complications during hospitalization. Timepoint: 7 days after admission. Method of measurement: Observation and questionnaire recording.;Intubation. Timepoint: 7 days after admission. Method of measurement: Observation and questionnaire recording.
- Secondary Outcome Measures
Name Time Method Hospitalization period. Timepoint: At discharge or death. Method of measurement: Observation and questionnaire recording.